» Articles » PMID: 34200502

The New Status of Parasitic Diseases in the COVID-19 Pandemic-Risk Factors or Protective Agents?

Overview
Journal J Clin Med
Specialty General Medicine
Date 2021 Jul 2
PMID 34200502
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

It is possible that parasites may influence the course of COVID-19 infection, as either risk factors or protective agents; as such, the current coronavirus pandemic may affect the diagnosis and prevention of parasitic disease, and its elimination programs. The present review highlights the similarity between the symptoms of human parasitoses and those of COVID-19 and discuss their mutual influence. The study evaluated selected human parasitoses with similar symptoms to COVID-19 and examined their potential influence on SARS-CoV-2 virus invasion. The available data suggest that at least several human parasitoses could result in misdiagnosis of COVID-19. Some disorders, such as malaria, schistosomiasis and soil-transmitted helminths, can increase the risk of severe infection with COVID-19. It is also suggested that recovery from parasitic disease can enhance the immune system and protect from COVID-19 infection. In addition, the COVID-19 pandemic has affected parasitic disease elimination programs in endemic regions and influenced the number of diagnoses of human parasitoses.

Citing Articles

Frontiers in superbug management: innovating approaches to combat antimicrobial resistance.

Chambial P, Thakur N, Bhukya P, Subbaiyan A, Kumar U Arch Microbiol. 2025; 207(3):60.

PMID: 39953143 DOI: 10.1007/s00203-025-04262-x.


A standardized combination of and extracts enhances immune function in adults: a pilot randomized, double-blind, placebo-controlled clinical study.

Sadhupati D, Lakshmisudha R, Chakravarthy K, Naidana P Food Nutr Res. 2024; 68.

PMID: 38863743 PMC: 11165258. DOI: 10.29219/fnr.v68.10297.


Cutaneous Leishmaniasis Hampers COVID-19: A Controlled Cross-Sectional Study in High-Burden Endemic Areas of Iran.

Bamorovat M, Sharifi I, Shafiei Bafti M, Agha Kuchak Afshari S, Aflatoonian M, Karamoozian A J Epidemiol Glob Health. 2024; 14(1):142-153.

PMID: 38190050 PMC: 11043327. DOI: 10.1007/s44197-023-00179-0.


Re-Emerging COVID-19: Controversy of Its Zoonotic Origin, Risks of Severity of Reinfection and Management.

Chala B, Tilaye T, Waktole G Int J Gen Med. 2023; 16:4307-4319.

PMID: 37753439 PMC: 10518360. DOI: 10.2147/IJGM.S419789.


Real-time impact of COVID-19 pandemic on cutaneous leishmaniasis case finding and strategic planning, preventive interventions, control and epidemiology in a region with a high burden of cutaneous leishmaniasis and COVID-19: A cross-sectional....

Shams M, Rashidi A, Mohamadi J, Moradi M, Pakzad R, Naserifar R Health Sci Rep. 2023; 6(8):e1489.

PMID: 37599657 PMC: 10432587. DOI: 10.1002/hsr2.1489.


References
1.
Kot K, Lanocha-Arendarczyk N, Kosik-Bogacka D . Amoebas from the genus Acanthamoeba and their pathogenic properties. Ann Parasitol. 2019; 64(4):299-308. View

2.
Siddiqui R, Khan N . Biology and pathogenesis of Acanthamoeba. Parasit Vectors. 2012; 5:6. PMC: 3284432. DOI: 10.1186/1756-3305-5-6. View

3.
Sanklecha M, Mehta N, Bagban H . Varied presentation of complicated falciparum malaria in a family. Indian Pediatr. 2012; 49(5):413-4. View

4.
Alexandrino-de-Oliveira P, Santos-Oliveira J, Dorval M, Da-Costa F, Pereira G, da Cunha R . HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Mem Inst Oswaldo Cruz. 2010; 105(5):692-7. DOI: 10.1590/s0074-02762010000500016. View

5.
Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F . COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020; 288(2):192-206. PMC: 7267177. DOI: 10.1111/joim.13091. View